Biotechnology CRISPR inventor Feng Zhang calls for moratorium on gene-edited babies A leading scientist wants Chinese researchers to halt a project to create genetically modified children. by Antonio Regalado 2018-11-26T08:57:00-05:00
Rewriting Life CRISPR Patent Outcome Won’t Slow Innovation The legal battle over who invented the powerful gene-editing tool isn’t likely to dim hopes for better crops and powerful new medical treatments. by Emily Mullin 2016-12-13T03:57:00-05:00
Rewriting Life Biotech Trial of the Century Could Determine Who Owns CRISPR Attorneys in a dispute over CRISPR gene-editing make their case to patent judges. by Jacob S. Sherkow 2016-12-07T11:49:00-05:00
Rewriting Life In CRISPR Fight, Co-Inventor Says Broad Institute Misled Patent Office New evidence in the battle to control a gene-editing technology that is worth billions. by Antonio Regalado 2016-08-17T13:10:00-04:00
Rewriting Life CRISPR Dispute to Be Decided by Patent Office A “patent interference” proceeding will determine who controls foundational patents on gene editing. by Jacob S. Sherkow 2016-01-12T11:37:00-05:00
Rewriting Life New CRISPR Protein Slices through Genomes, Patent Problems Scientists predict an explosion of new genome-editing methods. by Antonio Regalado 2015-09-25T12:00:00-04:00
Rewriting Life Gene-Editing Startup Raises $120 Million to Apply CRISPR to Medicine A company started by several gene-editing pioneers gets new funding to develop treatments for blood cancers, eye diseases, and sickle-cell anemia. by Anna Nowogrodzki 2015-08-10T07:30:00-04:00
Biotechnology Who Owns the Biggest Biotech Discovery of the Century? There’s a bitter fight over the patents for CRISPR, a breakthrough new form of DNA editing. by Antonio Regalado 2014-12-04T18:00:00-05:00
Rewriting Life EmTech: Risks of Gene-Editing Drugs Need Study, Pioneer Warns One of the inventors of gene editing says scientists should proceed cautiously before testing it in people. by Antonio Regalado 2014-09-24T12:24:00-04:00
Rewriting Life Broad Institute Gets Patent on Revolutionary Gene-Editing Method The Harvard-MIT genomic science institute stays mute on how it will assert control over the tools expected to speed cures and change gene therapy. by Susan Young Rojahn 2014-04-16T17:24:00-04:00
